Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA research hub

A Phase 2a Randomised, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of AZD4604 Twice Daily for Twelve Weeks in Adult Patients with Moderate to Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

This study is testing a new medicine, AZD4604, for adults with asthma that isn't well controlled, even with their usual inhalers. We want to see if it helps reduce asthma flare-ups and improve breathing, comparing it to a dummy medicine.